THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-130 Cr | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr | ₹-62 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-130 Cr |
| Mar2024 | ₹-85 Cr |
| Mar2023 | ₹-86 Cr |
| Mar2022 | ₹-89 Cr |
| Mar2021 | ₹-62 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-130 Cr | Negative | |
| Mar2024 | ₹-85 Cr | Negative | |
| Mar2023 | ₹-86 Cr | Negative | |
| Mar2022 | ₹-89 Cr | Negative | |
| Mar2021 | ₹-62 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹7,190.3 Cr | -5% | 14.5% | 41.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹115,331.0 Cr | 0% | 6.2% | 16.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹103,023.0 Cr | 3.9% | 6.8% | -10.5% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹72,638.3 Cr | 1.2% | 10.1% | 44.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹38,173.6 Cr | 1.3% | 5.3% | 3.9% | Stock Analytics | |
| GLOBAL HEALTH | ₹33,317.5 Cr | 4% | 13.3% | 0.2% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -5% |
14.5% |
41.1% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses